Vericel to Present at 29th Annual Piper Jaffray Healthcare Conference
November 16 2017 - 4:10PM
Vericel Corporation (NASDAQ:VCEL), a leading developer of expanded
autologous cell therapies for the treatment of patients with
serious diseases and conditions, today announced that Nick
Colangelo, president and CEO, will present the latest company
overview at the 29th Annual Piper Jaffray Healthcare Conference at
the Lotte New York Palace in New York City, NY on Wednesday,
November 29, 2017, at 2:00pm Eastern time.
The presentation will be webcast live at
https://pgi.webcasts.com/viewer/event.jsp?ei=1172021&tp_key=ab3cbde8f8,
and may be accessed from the news and events section of the Vericel
website.
About Vericel Corporation
Vericel develops, manufactures, and markets expanded autologous
cell therapies for the treatment of patients with serious diseases
and conditions. The company markets two cell therapy products in
the United States. Vericel is marketing MACI® (autologous cultured
chondrocytes on porcine collagen membrane), an autologous
cellularized scaffold product indicated for the repair of
symptomatic, single or multiple full-thickness cartilage defects of
the knee with or without bone involvement in adults. Vericel is
also marketing Epicel® (cultured epidermal autografts), a permanent
skin replacement for the treatment of patients with deep dermal or
full thickness burns greater than or equal to 30% of total body
surface area. For more information, please visit the company's
website at www.vcel.com.
Epicel® and MACI® are registered trademarks of Vericel
Corporation. © 2017 Vericel Corporation. All rights reserved.
Global Media Contacts:David SchullRusso
Partners LLC+1 212-845-4271 (office)+1 858-717-2310
(mobile)David.schull@russopartnersllc.com
Karen ChaseRusso Partners LLC+1 646-942-5627 (office)+1
917-547-0434 (mobile)Karen.chase@russopartnersllc.com
Investor Contacts:Chad RubinThe Trout
Groupcrubin@troutgroup.com+1 (646) 378-2947
Lee SternThe Trout Grouplstern@troutgroup.com+1 (646)
378-2922
Vericel (NASDAQ:VCEL)
Historical Stock Chart
From Aug 2024 to Sep 2024
Vericel (NASDAQ:VCEL)
Historical Stock Chart
From Sep 2023 to Sep 2024